Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This bill aims to make oral anticancer medications more affordable for people covered by certain health insurance plans in New Jersey. It limits upfront costs, such as prior authorization fees, deductibles, and copays, for these medications, ensuring coverage is no less favorable than for intravenously administered treatments. The bill applies to various types of health plans, including hospital service corporations, medical service corporations, health service corporations, individual health insurance policies, and group health insurance policies. It also impacts the State Health Benefits Commission and the School Employees’ Health Benefits Commission.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours